Adjunctive immunologic interventions in neonatal sepsis.

William Tarnow-Mordi, David Isaacs, Sourabh Dutta

Journal: Clinics in perinatology 2010;37(2):481-99

PMID: 20569818

Full Text on Elsevier Science View on PubMed

Abstract

Because of inadequate sample sizes of randomized controlled trials, few immunologic interventions to treat or prevent neonatal sepsis have been reliably evaluated. International collaboration is essential in achieving timely, adequate samples to assess effects on mortality or disability-free survival reliably. Promising or possible therapeutic interventions in severe or gram-negative sepsis include exchange transfusions, pentoxifylline, and IgM-enriched intravenous immunoglobulin. Promising or possible prophylactic interventions include lactoferrin, with or without a probiotic; selenium; early curtailment of antibiotics after sterile cultures; breast milk; and earlier initiation of colostrum in high risk preterm infants. Prophylactic oral probiotics are safe and effective (P<.00001) in reducing all-cause mortality and necrotizing enterocolitis in preterm infants by over half, but do not reduce sepsis.

Address: Westmead International Network for Neonatal Education and Research (WINNER) Institute, Centre for Newborn Care, Westmead Hospital, University of Sydney, Hawkesbury Road, New South Wales 2145, Australia. [email protected] <[email protected]>

DOI: 10.1016/j.clp.2009.12.002

Link outs

Free resources

Medical:

https://medlineplus.gov/sepsis.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Anti-Bacterial Agents, Breast Feeding, Exchange Transfusion, Whole Blood, Glutamine, Humans, Immunoglobulins, Intravenous, Infant, Newborn, Lactoferrin, Oxidative Stress, Pentoxifylline, Probiotics, Protein C, Randomized Controlled Trials as Topic, Selenium, Sepsis